Team
Andrew is a senior associate in the intellectual property team and provides advice on contentious and non-contentious patent issues. He has a particular interest in advising life sciences companies, following a previous career as a medicinal chemist in the pharmaceutical industry.
Since 2020 | Senior Associate, Taylor Wessing |
2015 - 2020 | Associate, Taylor Wessing |
2013 - 2015 | Trainee Solicitor , CMS Cameron McKenna |
2009 - 2013 | Group Leader, Medicinal Chemistry at Eisai |
2000 - 2009 | Team Leader, GlaxoSmithKline |
1998 - 1999 | Postdoctoral Researcher, The University of Texas at Austin |
2015 | Admitted as a lawyer, England & Wales |
2013 | LPC distinction, BPP Law School |
2011 | GDL commendation, BPP Law School, London |
1997 | PhD in synthetic organic chemistry from Imperial College, London |
1994 | BSc Hons Chemistry, Imperial College and Università degli Studi di Firenze, Italy |
Declaratory Relief in the English Patents Court, Bio-Science Law Review, 2016, p 123-128 |
English |
Aktuelle News & Insights
Brexit and beyond – Wellcome's recommendations from the Future Partnership Project
von Andrew Payne
Licence held to be exclusive despite option
von Andrew Payne
Data exclusivity for innovators - a bridge too far?
von Andrew Payne
High Court grants declaratory relief in pharmaceutical regulatory dispute
von Andrew Payne